Literature DB >> 27879161

Neopterin and oxidative stress markers in the diagnosis of extrapulmonary tuberculosis.

Nisha Goyal1, Bineeta Kashyap1, N P Singh1, Iqbal R Kaur1.   

Abstract

BACKGROUND: Extrapulmonary tuberculosis (EPTB) often presents with nonspecific signs and symptoms. Further the paucibacillary nature of extrapulmonary specimens and irregular distribution of bacilli lower the sensitivity of conventional diagnostic methods making EPTB, a diagnostic dilemma.
OBJECTIVE: To study neopterin, protein carbonyl and malondialdehyde (MDA) in EPTB.
METHODS: Sixty nine clinically confirmed cases with an equal number of age and sex matched healthy controls were enrolled. Ziehl-Neelsen staining for acid fast bacilli and culture on Lowenstein-Jensen medium were performed on all the extrapulmonary specimens. Serum neopterin and protein carbonyl levels were estimated using commercial ELISA kits. Malondialdehyde was determined by measuring thiobarbituric acid reactive substances.
RESULTS: Serum neopterin, protein carbonyl and MDA levels were significantly discriminative for cases of EPTB from healthy controls (p < 0.05). Levels of all the three biomarkers under study significantly differed between culture as well as smear positive and negative cases. A positive correlation between neopterin and protein carbonyl was seen among the cases.
CONCLUSIONS: So far few studies have integrated combination of validated host biomarkers for active disease in EPTB. Our study suggests the potential diagnostic role of neopterin, protein carbonyl and MDA in EPTB.

Entities:  

Keywords:  Extrapulmonary tuberculosis; biomarker; cytokine; neopterin; oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 27879161     DOI: 10.1080/1354750X.2016.1265005

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  7 in total

Review 1.  Types and functions of heterogeneity in mycobacteria.

Authors:  Eun Seon Chung; William C Johnson; Bree B Aldridge
Journal:  Nat Rev Microbiol       Date:  2022-04-01       Impact factor: 78.297

Review 2.  Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values.

Authors:  Kuldeep Dhama; Shyma K Latheef; Maryam Dadar; Hari Abdul Samad; Ashok Munjal; Rekha Khandia; Kumaragurubaran Karthik; Ruchi Tiwari; Mohd Iqbal Yatoo; Prakash Bhatt; Sandip Chakraborty; Karam Pal Singh; Hafiz M N Iqbal; Wanpen Chaicumpa; Sunil Kumar Joshi
Journal:  Front Mol Biosci       Date:  2019-10-18

Review 3.  The Interplay Between Systemic Inflammation, Oxidative Stress, and Tissue Remodeling in Tuberculosis.

Authors:  Eduardo P Amaral; Caian L Vinhaes; Deivide Oliveira-de-Souza; Betania Nogueira; Kevan M Akrami; Bruno B Andrade
Journal:  Antioxid Redox Signal       Date:  2020-06-19       Impact factor: 8.401

4.  Establishment a real-time reverse transcription PCR based on host biomarkers for the detection of the subclinical cases of Mycobacterium avium subsp. paratuberculosis.

Authors:  Hyun-Eui Park; Hong-Tae Park; Young Hoon Jung; Han Sang Yoo
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

Review 5.  Role of Oxidative Stress in the Pathology and Management of Human Tuberculosis.

Authors:  Madhur D Shastri; Shakti Dhar Shukla; Wai Chin Chong; Kamal Dua; Gregory M Peterson; Rahul P Patel; Philip M Hansbro; Rajaraman Eri; Ronan F O'Toole
Journal:  Oxid Med Cell Longev       Date:  2018-10-11       Impact factor: 6.543

6.  Ornithine-A urea cycle metabolite enhances autophagy and controls Mycobacterium tuberculosis infection.

Authors:  Ramya Sivangala Thandi; Rajesh Kumar Radhakrishnan; Deepak Tripathi; Padmaja Paidipally; Abul K Azad; Larry S Schlesinger; Buka Samten; Sachin Mulik; Ramakrishna Vankayalapati
Journal:  Nat Commun       Date:  2020-07-15       Impact factor: 17.694

Review 7.  The potential role of neopterin in Covid-19: a new perspective.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; Khalid J Alzahrani; Natália Cruz-Martins; Gaber El-Saber Batiha
Journal:  Mol Cell Biochem       Date:  2021-07-28       Impact factor: 3.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.